Vertex ends work on one hepatitis C drug, continues another

BOSTON (Reuters) - Vertex Pharmaceuticals Inc said on Tuesday it will discontinue development of an experimental drug to treat hepatitis C after it failed to show sufficient efficacy.

via Reuters: Health News Read More Here..